Details on monthly test strip subscription plan and our first impressions.
Type 1 Diabetes News
Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels.
27 readers recommended
The Annual TCOYD/The diaTribe Foundation Forum Celebrates its 10 th Anniversary in New Orleans
53 readers recommended
Adds waterproof, color screen, and remote meter bolus. Will it speed FDA review of the 670G hybrid closed loop?
37 readers recommended
Details for Dexcom July 21 Advisory Panel meeting posted. How to submit a written statement to the FDA or attend in person.
The diaTribe Foundation’s 2016 gathering shares need for earlier treatment, data integration, prevention, amplifying patient voices, and reducing stigma.
34 readers recommended
Type 1 diabetes has been prevented and cured in more than 500 ways in mice, but never in humans. nPOD researchers are trying to change that, one donated organ at a time.
42 readers recommended
Team Novo Nordisk athletes with diabetes dispel myths and stigma.
35 readers recommended
Plus, what people with diabetes and healthcare providers can do
46 readers recommended
No fingersticks needed? Plus, a look at the “thinnest CGM ever” from Dexcom and Verily
33 readers recommended
How many people have type 1? What are the barriers to using new therapies? What outcomes matter beyond A1c?
32 readers recommended
TCOYD’s CGM Medicare Appeals Assistance Program may be able to help!
32 readers recommended
Providers and patients will now see the same data - stay tuned for IBM Watson!
43 readers recommended
Available in US physicians’ offices in the next couple weeks; Real-time version submitted to FDA!
19 readers recommended
Our own Kelly Close moderates a panel at SXSW Interactive.
41 readers recommended
A call to action to make this invisible disease visible.
29 readers recommended
How I’m trying to beat my long list of “I should really...”
42 readers recommended
New ADA guidelines encourage interrupting long periods of sitting: improved blood glucose management and insulin sensitivity
46 readers recommended
Enrolling at over 140 sites worldwide. Can it reduce A1c and insulin use and improve time-in-range?
31 readers recommended
A1c cannot capture the whole picture – hypoglycemia, time in range, and quality of life add so much more!
29 readers recommended
Making major improvements over current standard of care – how does this new treatment work? The FDA recently approved a new indication for a product that has been used...